2 big Bay Area companies look to map, tackle inflammatory diseases

Scientific powerhouses Gilead Sciences Inc. and Verily Life Sciences will work together to find a molecular map of the immune system in lupus, rheumatoid arthritis and inflammatory bowel disease and how it responds to drugs in development. The deal, the value of which wasn't disclosed Monday, comes as the power of understanding and manipulating the immune system to tackle those conditions, cancer and other diseases has taken center stage over the past few years. Gilead (NASDAQ: GILD) will use the…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news